Skip to main content
. 2020 Mar 25;12(4):781. doi: 10.3390/cancers12040781

Figure 2.

Figure 2

Example of [18F]-FDHT-PET in a patient with metastasized prostate cancer: lymph node metastases in the neck, right hilus, retroperitoneal, para-iliacal and inguinal, bone metastases in the spine, ribs, pelvis and left femur.